Sponsorizzato
Novo Nordisk CEO to step down amid market challenges and stock plunge
Posted
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Cerca
Categorie
- National
- International
- Business
- Technology
- Health
- Formazione
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leggi tutto
IND vs ENG: 'Really annoying...' — King Charles III sympathises with India
Following a narrow defeat in the third Test match against England, King Charles III hosted and...
Home Ministry transfers five undersecretaries: Tiwari appointed Immigration DG, Ghimire heads TIA office
KATHMANDU: The Ministry of Home Affairs has transferred five joint secretaries, including...